This is an overview of the USAID/India FY 2022 Tuberculosis (TB) Roadmap, implemented with FY 2021 budget

TABLES

The following tables illustrate the distribution by technical area of the USAID TB budget for India that will be used for the implementation of India’s FY22 TB Roadmap (Table 1) and the core indicators that will be used to monitor implementation of India’s TB Roadmap and the country's progress towards the United Nations General Assembly High-Level Meeting on TB targets (UNGA targets) (Table 2).

Table 1: USAID Budget for India per Technical Area

Technical AreaUSAID TB budget for FY22USAID Percentage of TB budget for FY22
REACH$4,669,28131%
CURE$4,225,42928%
PREVENT$1,045,0617%
SUSTAINABLE SYSTEMS$5,060,22934%
TOTAL BUDGET:$15,000,000100%

Table 2: TB Core Indicators in India from 2015-2020 and Targets from 2021-2022

#Name201520162017201820192020*2021*2022*
REACH: Increased DS- and DR-TB case notification
1TB Detection58.7%63.2%60.2%74.1%81.9%62.9%UNGA target: 2,245,600UNGA target: 2,092,600
2Bacteriological Diagnosis Coverage (Pulmonary TB)63.9%62.6%71.1%56.7%57.0%54%  
3Childhood TB Notifications99,133104,886101,170129,510145,57497,539UNGA target: 271,000UNGA target: 265,800
4Drug-Resistant TB Notifications31,92439,72241,65961,74768,57849,679UNGA target: 110,210UNGA target: 124,050
5Private Sector TB Notifications542,527678,895559,923
6Contact Investigation Coverage**79.0%85%
CURE: High treatment success rate in DS- and DR-TB
7TB Treatment Success Rate***85.1%85.8%84.7%91.0%91%
8Drug-Resistant TB treatment Success Rate****46.9%47.1%48.0%56%
PREVENT: Prevent TB transmission and development
9TPT Coverage59187713,76121,841973,171437,311UNGA target: 1,867,020UNGA target: 2,252,910
SUSTAINABLE SYSTEMS: Commitment and sustainability
10Proportion of Domestic Financing for TB68.0%85.0%66.0%

*Projected Targets: These represent the United Nations General Assembly High-Level Meeting targets (UNGA targets).
**Contact Investigation Coverage: based on limited available data from 2016 to 2019, 2020 data is accurately reported.
***TB Treatment Success Rate: newest data for 2019 cohort reported.
****Drug-Resistant TB Treatment Success Rate: newest data for 2018 cohort reported.